Entero Healthcare Solutions Ltd IPO
Know more about Entero Healthcare Solutions Ltd IPO
Give a missed call
+91 99532 12345
Know more about Entero Healthcare Solutions Ltd IPO
Overview of Entero Healthcare Solutions Ltd IPO
IPO Date
9-Feb-2024 to 13-Feb-2024
Face Value
₹10 per share
Price Band
₹1195 to ₹1258
Lot Size
11 Share
Issue Size
12,718,600 shares (aggregating up to )
Listing At
BSE, NSE
Basis of Allotment
14-Feb-2024
Initiation of Refunds
15-Feb-2024
Credit of Shares to Demat
15-Feb-2024
Listing Date
16-Feb-2024
Cut off time for UPI Mandate
13-Feb-2024
Objective of Entero Healthcare Solutions Ltd IPO
The net proceeds from the issuance of 7,949,125 Equity Shares (worth Rs 1000 crs) will be utilized to repay debt (Rs 143 crs), funding working capital requirements (Rs 480 crs), and rest of the funds (Rs 378 crs) have been kept for general corporate purpose and pursuing inorganic growth initiatives through acquisitions.
About Entero Healthcare Solutions Ltd IPO
Entero Healthcare Solutions, incorporated in 2018, is amongst one of the top 3 healthcare products distributors in India, leveraging a technology driven platform to offer product distribution services to pharmacies, hospitals, and clinics. As of September,’23, the company has a pan-India presence and operates a vast network of 77 warehouses located in India and has served 73,700 retail customers. Further it has supply relationships with over 1900 healthcare product manufactures, providing access to about 63,900 product SKUs.
Entero Healthcare Solutions Ltd IPO Financials
Particulars (in Cr) | H1 FY24 | FY23 | FY22 | FY21 |
---|---|---|---|---|
Total Revenue Annual | 1,896 | 3,300 | 2,522 | 1,780 |
Operating Expenses Annual | 1,841 | 3,236 | 2,498 | 1,758 |
Operating Profit Annual | 54 | 64 | 24 | 22 |
Depreciation | 12 | 24 | 20 | 16 |
Interest Annual | 32 | 49 | 29 | 20 |
Tax Annual | 2 | 7 | 10 | 5 |
Net Profit Annual | 12 | -11 | -29 | -15 |
Total Share Holder Funds | 658 | 595 | 561 | 561 |
Fixed Asset Annual | 42 | 43 | 46 | 46 |
Total Non Current Asset | 290 | 286 | 275 | 275 |
Total Current Asset | 1,216 | 1,023 | 851 | 851 |
Total Asset Annual | 1,506 | 1,309 | 1,126 | 1,126 |
Book Value Per Share | ₹ 166.90 | ₹ 157.08 | ₹ 155.42 | ₹ 155.42 |
ROE | 2.54%* | -2.66% | -7.35% | -7.35% |
ROCE | 5.17%* | 6.05% | 1.49% | 1.49% |
Total Debt To Total Equity | 0.74 | 0.63 | 0.51 | 0.51 |
EBIDTA | 2.87% | 1.94% | 0.97% | 0.97% |
Cash From Operating | -83 | -45 | -35 | -35 |
Cash From Investing | -19 | -49 | -162 | -162 |
Cash From Finance | 127 | 73 | 211 | 211 |
Net Cash Flow | 52 | 25 | 47 | 47 |
Promoter's Holding
Total Share Capital
-
Offered to Public
-
Promoter’s Holding(Pre-Issue)
77.11%
Promoter’s Holding(Post-Issue)
-
1) Inorganic expansion via strategic acquisitions to enhance its geographic reach, revenue, and scalability. Over the past 5 years, the company has acquired 34 entities in the healthcare products distribution industry. Given the track record of effectively integrating these acquisitions, the company will continue to pursue acquisitions in the future as well.
2) Present in highly fragmented market of healthcare distribution products with high right to win from market consolidation.
3) Unique business model, leveraging technology to deliver purchasing experience through digital solutions such as Entero Direct, a direct B2B application.
4) Experienced management background with strong expertise in the pharma industry along with strong presence in the healthcare product distribution industry.
1) The company requires an adequate amount of working capital, as it needs to maintain substantial inventories.
2) Given the company’s focus of expanding its reach and scale of operations through acquisitions, so lower than expected synergies in integrating this acquisition could impact growth.
3) The company does not enter into long-term agreements with their customers, so any fluctuations in demand may affect the performance of the business.
4) The Indian pharmaceutical distribution market is very fragmented, with traditional local distributors holding significant market share, so industry consolidation could present highly competitive landscape.
Entero Healthcare Solutions is going public with a main-board IPO of 12,718,600 equity shares with a face value of ₹10, which will aggregate up to ₹1,600.00 Crores. The IPO has been priced at ₹1,195 to ₹1,258 per share, with a minimum order quantity of 11 shares.
The IPO will open on February 9, 2024, and close on February 13, 2024.
Link Intime India Private Ltd will serve as the registrar for the IPO. The shares are proposed to be listed on both BSE and NSE.
The Entero Healthcare Solutions IPO opens on February 9, 2024, and closes on February 13, 2024.
Entero Healthcare Solutions IPO lot size is 11 Shares, and the minimum amount required is ₹13,838.
The Entero Healthcare Solutions IPO listing date has not yet been announced. The tentative date of the Entero Healthcare Solutions IPO listing is Friday, February 16, 2024.
Stock of the Month Announced!
Grab this investment opportunity today!